Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Detection of Light-Chain Amyloidosis in Monoclonal Gammopathy Using 18F-Florbetaben PET/MR: a Prospective, Single-Center, Observational Study

NCT07624760 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT07624760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07624760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Detection of Light-Chain Amyloidosis in Monoclonal Gammopathy Using 18F-Florbetaben PET/MR: a Prospective, Single-Center, Observational Study
Lead sponsor
University of Zurich
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
May 31, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

al amyloidosis, monoclonal gammopathy, monoclonal gammopathy of undetermined significance (mgus), multiple myeloma, systemic amyloidosis